Keywords
Curation
Ncbi
Racine
Curation
Checkpoint
Ncbi
Racine
Ncbi
Exploration
Accueil
Racine
Racine

Serveur d'exploration sur le lymphœdème - Curation (Ncbi)

Index « Keywords » - entrée « Administration, Cutaneous »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Adjuvants, Immunologic (therapeutic use) < Administration, Cutaneous < Administration, Intranasal  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 8.
Ident.Authors (with country if any)Title
000A96 (2002) T K Suma [Inde] ; R K Shenoy ; V. KumaraswamiEfficacy and sustainability of a footcare programme in preventing acute attacks of adenolymphangitis in Brugian filariasis.
000C92 (????) Beatrice R. Amann-Vesti [Suisse] ; Gabriele Gitzelmann ; Renate Koppensteiner ; Ulrich K. FranzeckIsoprostane 8-epi-prostaglandin F2 alpha decreases lymph capillary pressure in patients with primary lymphedema.
000E66 (1992) J R Casley-Smith [Australie] ; J R Casley-SmithModern treatment of lymphoedema. II. The benzopyrones.
001A91 (????) Jason Boyd [États-Unis] ; Steven Sloan ; Jeffrey MeffertElephantiasis nostrum verrucosa of the abdomen: clinical results with tazarotene.
002F76 (2008) Nicholas W. Clavin [États-Unis] ; Tomer Avraham ; John Fernandez ; Sanjay V. Daluvoy ; Marc A. Soares ; Arif Chaudhry ; Babak J. MehraraTGF-beta1 is a negative regulator of lymphatic regeneration during wound repair.
007431 (2015) Muthu Sendhil Kumaran [Inde] ; Pinaki Dutta [Inde] ; Uma Sakia [Inde] ; Sunil Dogra [Inde]Long-term follow-up and epidemiological trends in patients with pretibial myxedema: an 11-year study from a tertiary care center in northern India.
007458 (2015) K. Papp [Canada] ; D. Thaçi [Allemagne] ; K. Reich [Allemagne] ; E. Riedl [Autriche] ; R G Langley [Canada] ; J G Krueger [États-Unis] ; A B Gottlieb [États-Unis] ; H. Nakagawa [Japon] ; E P Bowman [États-Unis] ; A. Mehta [États-Unis] ; Q. Li [États-Unis] ; Y. Zhou [États-Unis] ; R. Shames [États-Unis]Tildrakizumab (MK-3222), an anti-interleukin-23p19 monoclonal antibody, improves psoriasis in a phase IIb randomized placebo-controlled trial.
00BB16 (1998) A M Stazzone ; P. Borgs ; C L Witte ; M H WitteLymphangitis and refractory lymphedema after treatment with topical cantharidin.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Administration, Cutaneous" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Administration, Cutaneous" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Administration, Cutaneous
}}
Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024